Patients between the ages of 40 and 70 who undergo aortic valve replacement (AVR) may fare better with tissue-based valves than metal-based valves, according to a review article posted online by The Annals of Thoracic Surgery.
CardioKinetix Inc. announced that it has enrolled more than half of the subjects in its pivotal United States trial, PARACHUTE IV. The trial is evaluating the Parachute device for the treatment of patients suffering from heart failure, a highly debilitating condition.
The Centers for Medicare and Medicaid Services (CMS) announced Monday that it will be ending the Meaningful Use program that was meant to encourage the adoption of electronic medical records (EMR).
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
January 15, 2016 — The U.S. Food and Drug Administration (FDA) has given its approval for an expanded indication study ...
January 14, 2016 — Cornell biomedical engineers have discovered natural triggers that could reduce the chance of life ...
Penumbra Inc. announced the U.S. launch of its new POD Packing Coil, designed as a complementary device for Penumbra’s Ruby and POD (Penumbra Occlusion Device) embolization products.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
The American Medical Association (AMA) announced that it is investing $15M to become founding partner of a healthcare innovation company — Health2047 Inc.
Ionizing radiation can save lives, but it can also cause serious harm. Getting the right measurement of exposure to ionizing radiation in any situation is at the heart of an ISO standard that has recently been updated.
Even though brain natriuretic peptide (BNP)/pro-BNP and troponin biomarkers are the gold standard for cardiac disease diagnosis, end users will soon see additional alternative biomarkers entering the market, according to analysis from Frost & Sullivan.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Beyond measuring blood flow, pressure, oxygen levels and other vital signs in the cardiac catheterization lab, current ...
Each year radiology vendors use the Radiological Society of North America (RSNA) meeting as a springboard to unveil ...
NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the next-generation reusable cryoplasty inflation device.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Consumers from California, Colorado and Wisconsin filed a nationwide class action lawsuit against Fitbit Inc. alleging the company’s wrist-based “Charge HR” and “Surge” heart rate monitors do not and cannot consistently record accurate heart rates during the intense physical activity for which Fitbit expressly markets the devices.
GE Healthcare announced that it has chosen Chicago as its global headquarters, effective early 2016.
Fujifilm VisualSonics Inc. announced CE mark for the Vevo MD, what the company calls the world’s first ultra-high frequency (UHF) clinical ultrasound system. The announcement marks Fujifilm VisualSonics’ expansion into the clinical market.
January 15, 2016
